CASI Pharmaceuticals, Inc. (CASIF) › Shareholders' EquityCASI Pharmaceuticals, Inc. (CASIF) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2019: $73.00M2020: $81.54M2021: $84.50M2022: $44.57M2023: $24.16M2024: $1.85M2025: -$37.28M-$37.28M2019Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025-$37.28M-2114.2%2024$1.85M-92.3%2023$24.16M-45.8%2022$44.57M-47.3%2021$84.50M+3.6%2020$81.54M+11.7%2019$73.00M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share